Skip to main content
logo
LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.0670
-0.0030 (-4.29%)
Inactive · Last trade price on Jun 16, 2026

LakeShore Biopharma Financials Overview

Millions CNY. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
614.96614.96573.42687.2502.95257.02
Revenue Growth
-6.54%7.25%-16.56%36.63%95.69%-
Gross Profit
507.19507.19386.06533.84381.49197.36
Operating Income
-49.58-49.58-358.09-130.73-113.88-125.85
Net Income
-99.98-99.98-433.46-145.48-106-191.83
Earnings Per Share
-5.22-5.22-40.54-23.55-17.15-31.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Investments
28.0828.08246.35370.11271.07390.46
Total Debt
414.4414.4424.46498.63380.5918.44
Net Cash (Debt)
-386.32-386.32-178.11-128.52-109.52372.02
Net Cash Growth
------
Net Cash Per Share
-20.16-20.16-16.66-20.80-17.7160.17

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Cash Flow
-120.98-120.98-295.23-182.47-173.55-246.61
Capital Expenditures
-12.71-12.71-44.25-52.76-295.31-104.88
Free Cash Flow
-133.69-133.69-339.48-235.23-468.86-351.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Gross Margin
82.47%82.47%67.33%77.68%75.85%76.79%
Operating Margin
-8.06%-8.06%-62.45%-19.02%-22.64%-48.96%
Pretax Margin
-16.41%-16.41%-79.38%-41.09%-46.07%-74.31%
Profit Margin
-16.26%-16.26%-75.59%-21.17%-21.08%-74.64%
FCF Margin
-21.74%-21.74%-59.20%-34.23%-93.22%-136.76%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
PS Ratio
0.030.551.711.492.94-